Literature DB >> 15789197

[Dyskeratosis congenita in a 40-year-old patient].

S Benoit1, D Kraemer, E-B Bröcker, M Goebeler.   

Abstract

A 40-year-old patient with a 3-year history of thrombocytopenia was admitted with reticulated and speckled hyper- and hypopigmentations especially on the upper trunk. Aplasia or dystrophy of the fingernails and toenails as well as atresia of the lacrimal ducts were noted. Examination of the oropharynx revealed multiple mucosal leukoplakias and loss of almost all teeth. Based on these observations the diagnosis of X-linked dyskeratosis congenita (Zinsser-Cole-Engman syndrome, OMIM #305000) was made and confirmed by sequencing of the dyskerin 1 (DKC1) gene which revealed a missense mutation in exon 11.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15789197     DOI: 10.1007/s00105-005-0937-2

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  7 in total

Review 1.  Dyskeratosis congenita: its link to telomerase and aplastic anaemia.

Authors:  Inderjeet Dokal; Tom Vulliamy
Journal:  Blood Rev       Date:  2003-12       Impact factor: 8.250

2.  Treatment of neutropenia associated with dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor.

Authors:  C L Russo; B E Glader; R J Israel; F Galasso
Journal:  Lancet       Date:  1990-09-22       Impact factor: 79.321

3.  Missense mutation in a patient with X-linked dyskeratosis congenita.

Authors:  Doris M Kraemer; Matthias Goebeler
Journal:  Haematologica       Date:  2003-04       Impact factor: 9.941

4.  X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene.

Authors:  S W Knight; N S Heiss; T J Vulliamy; S Greschner; G Stavrides; G S Pai; G Lestringant; N Varma; P J Mason; I Dokal; A Poustka
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

5.  Treatment of dyskeratosis congenita with granulocyte colony-stimulating factor and erythropoietin.

Authors:  B P Alter; F H Gardner; R E Hall
Journal:  Br J Haematol       Date:  1997-05       Impact factor: 6.998

Review 6.  Dyskeratosis congenita, telomeres and human ageing.

Authors:  R A Marciniak; F B Johnson; L Guarente
Journal:  Trends Genet       Date:  2000-05       Impact factor: 11.639

7.  Unusual complications after bone marrow transplantation for dyskeratosis congenita.

Authors:  V Rocha; A Devergie; G Socié; P Ribaud; H Espérou; N Parquet; E Gluckman
Journal:  Br J Haematol       Date:  1998-10       Impact factor: 6.998

  7 in total
  1 in total

1.  Inactivation of the tumor suppressor genes causing the hereditary syndromes predisposing to head and neck cancer via promoter hypermethylation in sporadic head and neck cancers.

Authors:  Ian M Smith; Suhail K Mithani; Wojciech K Mydlarz; Steven S Chang; Joseph A Califano
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2010-03-24       Impact factor: 1.538

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.